Interleukin 2 is an Upstream Regulator of CD4+ T Cells From Visceral Leishmaniasis Patients With Therapeutic Potential

The Journal of Infectious Diseases
Shashi Bhushan ChauhanChristian Engwerda

Abstract

Control of visceral leishmaniasis (VL) caused by Leishmania donovani requires interferon-γ production by CD4+ T cells. In VL patients, antiparasitic CD4+ T-cell responses are ineffective for unknown reasons. In this study, we measured the expression of genes associated with various immune functions in these cells from VL patients and compared them to CD4+ T cells from the same patients after drug treatment and from endemic controls. We found reduced GATA3, RORC, and FOXP3 gene expression in CD4+ T cells of VL patients, associated with reduced Th2, Th17, and FOXP3+CD4+ T regulatory cell frequencies in VL patient blood. Interleukin 2 (IL-2) was an important upstream regulator of CD4+ T cells from VL patients, and functional studies demonstrated the therapeutic potential of IL-2 for improving antiparasitic immunity. Together, these results provide new insights into the characteristics of CD4+ T cells from VL patients that can be used to improve antiparasitic immune responses.

References

Jan 1, 1988·Advances in Immunology·K A Smith
Dec 1, 1993·The Journal of Clinical Investigation·B J HoladayR M Locksley
Jul 1, 1993·The Journal of Clinical Investigation·H W GhalibS G Reed
Apr 1, 1996·The Journal of Infectious Diseases·H W MurrayR E Fichtl
Feb 1, 2000·Immunology Today·C R Engwerda, P M Kaye
Feb 28, 2002·Annual Review of Immunology·Charles A Janeway, Ruslan Medzhitov
Apr 23, 2004·Expert Opinion on Biological Therapy·David F McDermott, Michael B Atkins
Jun 21, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Lucia E RosasAbhay R Satoskar
Jan 4, 2007·The Journal of Experimental Medicine·Katharina LahlTim Sparwasser
May 9, 2007·Nature Immunology·Eva V Acosta-RodriguezGiorgio Napolitani
May 31, 2008·Cell·Shimon SakaguchiMasahiro Ono
May 12, 2009·Immunological Reviews·Raul ElguetaRandolph J Noelle
Feb 6, 2010·Proceedings of the National Academy of Sciences of the United States of America·Sven LétourneauOnur Boyman
Mar 3, 2010·Annual Review of Immunology·Jinfang ZhuWilliam E Paul
Mar 2, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Nasim Akhtar AnsariDavid Sacks
Mar 19, 2014·The Journal of Immunology : Official Journal of the American Association of Immunologists·Patrick T BunnChristian R Engwerda
Apr 4, 2014·Clinical Microbiology Reviews·Noah J Tubo, Marc K Jenkins
Oct 30, 2014·Frontiers in Immunology·Christian R EngwerdaPatrick T Bunn
Jan 15, 2016·PLoS Pathogens·Marcela Montes de OcaChristian R Engwerda
Nov 10, 2016·PLoS Neglected Tropical Diseases·Luiz Gustavo GardinassiIsabel Kinney Ferreira de Miranda Santos
Nov 24, 2017·Frontiers in Immunology·Rajiv KumarChristian R Engwerda
May 15, 2018·The Journal of Infectious Diseases·Chelsea L EdwardsChristian R Engwerda
May 22, 2018·Frontiers in Immunology·Flávia CastroMaria José Oliveira
Aug 10, 2018·Nature Reviews. Immunology·Rosanne SpolskiWarren J Leonard

❮ Previous
Next ❯

Related Concepts

Related Feeds